Co-Activation of Cultured Human Natural Killer Cells: Enhanced Function and Decreased Inhibition

References

• Bryceson, Y. T., March, M. E., Ljunggren, H. G., and Long, E. O. 2006a. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214:73–91.
   PubMed Web of Science ®Google Scholar
• Bryceson, Y. T., March, M. E., Ljunggren, H. G., and Long, E. O. 2006b. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107:159–166.
   PubMed Web of Science ®Google Scholar
• Cederbrant, K., Marcusson-Stahl, M., Condevaux, F., and Descotes, J. 2003. NK-cell activity in immunotoxicity drug evaluation. Toxicology 185:241–250.
   PubMed Web of Science ®Google Scholar
• Coelho, P., Garcia-Leston, J., Costa, S., Costa, C., Silva, S., Fuchs, D., and Geisler, S. 2014. Immunological alterations in individuals exposed to metal(loid)s in the Panasqueira mining area, central Portugal. Sci. Total. Environ. 475:1–7.
   PubMed Web of Science ®Google Scholar
• Cohnen, A., Chiang, S. C., Stojanovic, A., Schmidt, H., Claus, M., Saftig, P., Janssen, O., Cerwenka, A., Bryceson, Y. T., and Watzl, C. 2013. Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage. Blood 122:1411–1418.
   PubMed Web of Science ®Google Scholar
• Eissmann, P., and Watzl, C. 2006. Molecular analysis of NTB-A signaling: A role for EAT-2 in NTB-A-mediated activation of human NK cells. J. Immunol. 177:3170–3177.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. 2000. Note for guidance on repeated dose toxicity. CPMP/SWP/1042/99. EMEA. www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500003102&mid=WC0b01ac058009a3dcoralternativelyjustwww.ema.europa.eu/ema/
   Google Scholar
• Endt, J., McCann, F. E., Almeida, C. R., Urlaub, D., Leung, R., Pende, D., Davis, D. M., and Watzl, C. 2007. Inhibitory receptor signals suppress ligation-induced recruitment of NKG2D to GM1-rich membrane domains at the human NK cell immune synapse. J. Immunol. 178:5606–5611.
   PubMed Web of Science ®Google Scholar
• Kim, H. S., Das, A., Gross, C. C., Bryceson, Y. T., and Long, E. O. 2010. Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase. Immunity 32:175–186.
   PubMed Web of Science ®Google Scholar
• Kim, H. S., and Long, E. O. 2012. Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells. Sci. Signal. 5: ra49.
   PubMed Web of Science ®Google Scholar
• Koch, J., Steinle, A., Watzl, C., and Mandelboim, O. 2013. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol. 34:182–191.
   PubMed Web of Science ®Google Scholar
• Kruse, P. H., Matta, J., Ugolini, S., and Vivier, E. 2014. Natural cytotoxicity receptors and their ligands. Immunol. Cell Biol. 92: 221–229.
   PubMed Web of Science ®Google Scholar
• Laffon, B., Aguilera, F., Rios-Vazquez, J., Garcia-Leston, J., Fuchs, D., Valdiglesias, V., and Pasaro, E. 2013. Endocrine and immunological parameters in individuals involved in Prestige spill cleanup tasks seven years after the exposure. Environ. Int. 59:103–111.
   PubMed Web of Science ®Google Scholar
• Long, E. O., Kim, H. S., Liu, D., Peterson, M. E., and Rajagopalan, S. 2013. Controlling natural killer cell responses: Integration of signals for activation and inhibition. Annu. Rev. Immunol. 31:227–258.
   PubMed Web of Science ®Google Scholar
• Mace, E. M., Dongre, P., Hsu, H. T., Sinha, P., James, A. M., Mann, S. S., Forbes, L. R., Watkin, L. B., and Orange, J. S. 2014. Cell biological steps and checkpoints in accessing NK cell cytotoxicity. Immunol. Cell Biol. 92:245–255.
   PubMed Web of Science ®Google Scholar
• Mesecke, S., Urlaub, D., Busch, H., Eils, R., and Watzl, C. 2011. Integration of activating and inhibitory receptor signaling by regulated phosphorylation of Vav1 in immune cells. Sci. Signal. 4:ra36.
   PubMed Web of Science ®Google Scholar
• Messmer, B., Eissmann, P., Stark, S., and Watzl, C. 2006. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells. J. Immunol. 176:4646–4650.
   PubMed Web of Science ®Google Scholar
• Romagne, F., and Vivier, E. 2011. Natural killer cell-based therapies. F1000 Med. Rep. 3:9.
   PubMedGoogle Scholar
• Sandusky, M. M., Messmer, B., and Watzl, C. 2006. Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation. Eur. J. Immunol. 36:3268–3276.
   PubMed Web of Science ®Google Scholar
• Stebbins, C. C., Watzl, C., Billadeau, D. D., Leibson, P. J., Burshtyn, D. N., and Long, E. O. 2003. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol. Cell. Biol. 23:6291–6299.
   PubMed Web of Science ®Google Scholar
• Vivier, E., Tomasello, E., Baratin, M., Walzer, T., and Ugolini, S. 2008. Functions of natural killer cells. Nat. Immunol. 9:503–510.
   PubMed Web of Science ®Google Scholar
• Watzl, C. 2014. How to trigger a killer: Modulation of natural killer cell reactivity on many levels. Adv. Immunol. 124:137–170.
   PubMed Web of Science ®Google Scholar
• Watzl, C., and Long, E. O. 2003. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J. Exp. Med. 197:77–85.
   PubMed Web of Science ®Google Scholar
• Watzl, C., and Long, E. O. 2010. Signal transduction during activation and inhibition of natural killer cells. Curr. Protocols Immunol. Chapter 11:Unit11.9B.
   Google Scholar
• Watzl, C., Stebbins, C. C., and Long, E. O. 2000. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J. Immunol. 165:3545–3548.
   PubMed Web of Science ®Google Scholar
• Watzl, C., and Urlaub, D. 2012. Molecular mechanisms of natural killer cell regulation. Front. Biosci. (Landmark Ed.) 17:1418–1432.
   PubMed Web of Science ®Google Scholar
• Wei, S., Gilvary, D. L., Corliss, B. C., Sebti, S., Sun, J., Straus, D. B., and Leibson, P. J. 2000. Direct tumor lysis by NK cells uses a Ras-independent mitogen-activated protein kinase signal pathway. J. Immunol. 165:3811–3819.
   PubMed Web of Science ®Google Scholar